Papers by Amit Nussbacher
Arquivos brasileiros de cardiologia, 2005
We investigated whether Chlamydia pneumoniae (CP) and Mycoplasma pneumoniae (MP) are present in a... more We investigated whether Chlamydia pneumoniae (CP) and Mycoplasma pneumoniae (MP) are present in aortic valve stenosis (AS). Immunohistochemistry was utilized to identify CP antigens, in situ hybridization to identify MP DNA, and electron microscopy was used to evaluate the following three groups: Normal - 11 normal autopsy valves; Atherosclerosis - 10 autopsy valves from patients with systemic atherosclerosis and no AS; and AS - 14 surgical specimens of AS analyzed in 3 sub-regions: AS-Preserved - peripheral, preserved regions; AS-Fibrosis - peri-calcified fibrotic tissue; and AS-Calcification - calcified nodules. The positive area fraction of CP antigen median values were 0.09, 0.30, 0.18, 1.33, and 3.3 in groups Normal, Atherosclerosis, AS-Preserved, AS-Fibrosis, and AS-Calcification, respectively. CP density was significantly greater in Atherosclerosis and AS-Calcification than in Normal (P<0.05). Within the AS group, the amount of CP was greater in the Calcification and Fibro...
Arquivos brasileiros de cardiologia, 2010
Psychosomatics, 2007
The authors evaluated levels of inflammatory markers in 34 chronic heart failure (CHF) outpatient... more The authors evaluated levels of inflammatory markers in 34 chronic heart failure (CHF) outpatients age 65 years and over, with (N)81ס and without (N)61ס major depressive disorder (MDD), and healthy-control subjects (N.)31ס Patients with CHF had left-ventricular ejection fractions Ͻ0.40 and were in the New York Heart Association functional class II or III. The authors used the SCID DSM-IV to diagnosis MDD. High-sensitivity C-reactive protein levels were significantly higher in patients with CHF and MDD as compared with healthy-control subjects. No differences regarding tumor necrosis factor ␣ or interleukin 6 were found among the three groups.
Metabolism, 2006
The effects of isolated estrogen therapy on the hemostatic system and arterial distensibility wer... more The effects of isolated estrogen therapy on the hemostatic system and arterial distensibility were determined in postmenopausal females with type 2 diabetes mellitus. This was a prospective nonrandomized study of 19 subjects (age, 56.2 F 4.7 years; body mass index, 27.8 F 2.4 kg/m 2 [mean F SD]). Inclusion was done after 2 months of glycemic and blood pressure control. The study consisted of 4 months of placebo treatment immediately followed by an equal period of oral conjugated equine estrogens (CEE) 0.625 mg/d. Measures included anthropometrics, a metabolic profile (oral glucose tolerance test and fasting glycated hemoglobin, total cholesterol and fractions, and triglyceride levels), and coagulation and fibrinolytic factors at the end of the placebo period and after 4 months of oral CEE. Conjugated equine estrogen therapy decreased plasminogen activator inhibitor 1 (placebo  CEE: 16.33 F 9.11  13.08 F 8.87 UI/mL, P b .03) and increased factor VIII activity (134.11% F 46.18%  145.33% F 42.04%, P b .04). An increase in high-density lipoprotein cholesterol levels (placebo  CEE: 42.47 F 6.80  53.32 F 11.89 mg/dL, P b .01), and a decrease in glycated hemoglobin (8.45% F 1.30% vs 7.58% F 1.06%, P b .02) and in fasting glucose levels (121.51 F 21.05 x111.21 F 20.74 mg/dL, P = .02) followed CEE therapy. Pulse wave velocity and augmentation index were performed by applanation tonometry and were obtained at the end of the placebo period (placebo), again after an intravenous load of 1.25 mg of CEE (short-term), and after 4 months of oral CEE (long-term). A significant decrease in central (carotidfemoral) pulse wave velocity was seen both after short-and long-term CEE (placebo vs short-term vs long-term: 9.36 F 2.58 vs 8.26 F 2.20 vs 7.98 F 1.90 m/s, respectively [analysis of variance, P b .03]; placebo vs short-term, P b .05; placebo vs long-term, P b .01), whereas augmentation index decreased only after long-term CEE (placebo vs short-term vs long-term: 39.14% F 6.94% vs 37.48% F 8.67% vs 34.3.3% F 8.11% [analysis of variance, P b .05], respectively; placebo vs long-term, P b .05). Long-term administration of CEE leads to an improvement in fibrinolysis and arterial distensibility, associated with an increase of the intrinsic coagulation pathway in postmenopausal women with type 2 diabetes mellitus. D
Journal of the American College of Cardiology, 2002
Background: Fibroblast growth factor-2 (FGF-2) is a potent angiogenic agent in multiple preclinic... more Background: Fibroblast growth factor-2 (FGF-2) is a potent angiogenic agent in multiple preclinical models. A single intra-arterial infusion of 30 mcg/kg rFGF-2 was associated with significant improvement in peak walking time (PWT) at 90 days in a phase II, randomized, placebo-controlled trial in patients with moderate to severe claudication (TRAF-FIC). Nicotine has angiogenic activity. A pro specified subgroup analysis was based on baseline smoking status.
Journal of the American College of Cardiology, 2002
sitivity of 58% and specificity of 91% for identifying lesion type B2+C by ACC/AHA guide line. Co... more sitivity of 58% and specificity of 91% for identifying lesion type B2+C by ACC/AHA guide line. Conclusion: Direction and velocity of baseline coronary flow using transthoracic Doppler echocardiography provide clinically valuable informations about the condition of coronary artery. Especially, slow flow predicts the pathologic flow dynamics of coronary art~des.
International Journal of Cardiology, 2006
Background: The process of aortic degeneration associated with calcified aortic stenosis shares m... more Background: The process of aortic degeneration associated with calcified aortic stenosis shares many similarities with coronary artery atherosclerosis. Inflammation and infection are involved in both diseases. Chlamydia pneumoniae has been identified in atherosclerotic plaques. However, the studies about the presence of C. pneumoniae in degenerative aortic stenotic valves are not conclusive.
International Journal of Cardiology, 2007
Metabolic syndrome and abdominal obesity are risk factors for cardiovascular diseases in middle a... more Metabolic syndrome and abdominal obesity are risk factors for cardiovascular diseases in middle age women but, not completely understood in older people. In this study we analyzed the association between metabolic syndrome and abdominal obesity and the occurrence of cardiovascular events in these elderly women. A prospective follow-up study included 516 consecutive women aged 60-84 years who sought medical care at a geriatric outpatient facility. The presence of metabolic syndrome and higher quartiles of waist circumference and waist-to-hip ratio were analyzed as predictive variables, and were adjusted for age, smoking, and previous cardiovascular diseases. The outcomes were the occurrence of stroke, myocardial infarction, evidence of coronary artery disease, or cardiovascular death. During a mean follow-up of 6.6 years, 94 (18.2%) cardiovascular events were observed (48 fatal and 46 non-fatal). Metabolic syndrome was diagnosed in 206 women (39.9%). After adjustments for confounding variables, metabolic syndrome and waist-to-hip ratio above the 75th percentile (&amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;gt;0.98) were predictors of the outcomes, but greater waist circumference (&amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;gt;96 cm) was not. Adjusted hazard ratios for these variables were: metabolic syndrome, 1.66, 95% CI -1.11 to 2.47, p=0.01; waist-to-hip ratio, 1.72, 95% CI -1.05 to 2.82; p=0.03 and waist circumference, 1.37, 95% CI -0.91 to 2.07, p=0.12. Metabolic syndrome and high waist-to-hip ratio were associated with increased risk of cardiovascular events in the studied sample.
International Journal of Cardiology, 1998
We studied the incidence of AF in patients with endomyocardial fibrosis (EMF) and its influence o... more We studied the incidence of AF in patients with endomyocardial fibrosis (EMF) and its influence on prognosis and associated clinical events. One hundred and sixty consecutive patients with EMF were followed for a mean period of 4 years. Their mean age was 39.7 years. There were 114 women. During follow-up there were 56 deaths. Eighty-eight patients (55%) were submitted to surgical intervention. AF was observed in 58 cases (36.2%). The presence of AF was associated with a greater prevalence of dyspnea, peripheral edema, hepatomegaly, lower left ventricular ejection fraction, lower right ventricular systolic pressure (37.8 vs 45.6 mmHg, P=0.0392), and greater incidence of tricuspid regurgitation (86.0 vs 63.2%, P=0.004). AF was more frequent among patients in whom the disease involved the right ventricle, particularly those with intense fibrosis. Overall, patients with AF had a higher mortality rate than those who did not have AF (43.1 vs 30.3%, P=0.0195), but among those submitted to surgery, AF did not have an impact on survival. In conclusion, AF is frequent among patients with EMF. It is more prevalent among patients with right ventricular involvement and its presence is associated with a greater incidence of heart failure. AF is associated with worse prognosis, but surgery potentially reverses this bad evolution.
Arquivos Brasileiros de Cardiologia, 2001
Objective -Antihypertensive therapy with thiazides decreases coronary events in elderly patients.... more Objective -Antihypertensive therapy with thiazides decreases coronary events in elderly patients. However, the influence of diuretics on myocardial ischemia has not been fully investigated. The aim of this study was to compare the effect of chlorthalidone and diltiazem on myocardial ischemia.
Arquivos Brasileiros de Cardiologia, 1997
Objetivo-Avaliar as formas de apresentação da amilóidose cardíaca em hospital terciário. Métodos-... more Objetivo-Avaliar as formas de apresentação da amilóidose cardíaca em hospital terciário. Métodos-Nos últimos 15 anos, foram identificados 8 pacientes com amilóidose, sendo 5 mulheres, com idades entre 23 e 83 (média 62) anos. Após anamnese e exame físico ...
Arquivos Brasileiros de Cardiologia, 2004
Recebido para publicação em 8/11/02 Aceito em 17/3/04 Objetivo Avaliar se a terapia de reposição ... more Recebido para publicação em 8/11/02 Aceito em 17/3/04 Objetivo Avaliar se a terapia de reposição hormonal com estrogênios e progestogênios, em mulheres hipertensas na pós-menopausa, modifica a trigliceridemia e a reatividade vascular pós-prandial. Métodos Estudo controlado, duplo cego, cruzado contra placebo em 15 mulheres na pós-menopausa (idade de 50 a 70, média = 61,6 ± 6 anos), sorteadas para 2 semanas de placebo ou ingestão oral de 0,625 mg de estrogênios conjugados eqüinos e 2,5 mg de medroxiprogesterona e alimentadas com refeição rica em gorduras (897 calorias; 50,1% de gorduras). Foi medida a reatividade vascular (RV -% de variação dos diâmetros do vaso entre o jejum e 2h após a alimentação), usando-se método ultra-sonográfico automatizado. Foram também determinados o perfil lipídico e a glicose, em jejum e 2h após a alimentação rica em gorduras.
Arquivos Brasileiros de Cardiologia, 2005
... Marilia Harumi Higuchi-dos-Santos, Humberto Pierri, Maria de Lourdes Higuchi, Amit Nussbacher... more ... Marilia Harumi Higuchi-dos-Santos, Humberto Pierri, Maria de Lourdes Higuchi, Amit Nussbacher, Sueli Palomino, Nadia Vieira Sambiase, José Antonio Franchini Ramires, Maurício Wajngarten ... Referências 4. Mohler ER, Sheridan MJ, Nichols R, Harvey WP, Waller BF. ...
Arquivos Brasileiros de Cardiologia, 2004
Admite-se que as drogas bloqueadoras beta-adrenérgicas, freqüentemente utilizadas na terapêutica ... more Admite-se que as drogas bloqueadoras beta-adrenérgicas, freqüentemente utilizadas na terapêutica da doença coronariana e da insuficiência cardíaca 1,2 , são capazes de reduzir o risco de mortalidade por infarto agudo do miocárdio e de reinfarto 3 . Apesar dos reconhecidos benefícios, seu emprego no idoso -condição etária mais acometida pela doença coronariana -é menos comum do que no indivíduo mais jovem, devido ao receio de ocorrência de efeitos adversos, inclusive desenvolvimento de insuficiência cardíaca 4 .
Revista da Associação Médica Brasileira, 2004
Paciente de 50 anos, hipertenso, procurou atendimento médico devido a cansaço aos esforços. O eco... more Paciente de 50 anos, hipertenso, procurou atendimento médico devido a cansaço aos esforços. O ecodopplercardiograma mostrou hipocontratilidade difusa (FE: 41%), o que não foi encontrado em exames anteriores de rotina. A ressonância magnética revelou redução da função do ventrículo esquerdo (VE) e um padrão característico de miocárdio não-compactado. Normalmente, o VE exibe três trabeculações proeminentes. O encontro de mais de três trabeculações define o diagnóstico de miocárdio não-compactado.
The American Journal of Geriatric Cardiology, 2003
In this study the authors sought to determine the prevalence and long-term prognostic value of lo... more In this study the authors sought to determine the prevalence and long-term prognostic value of low triiodothyronine levels in elderly patients with heart failure and no thyroid disease. Lower levels of triiodothyronine are more prevalent in patients with advanced heart failure without thyroid disease, and this may have prognostic implications. However, this hormonal milieu has not been investigated in elderly patients. The authors prospectively followed a consecutive sample of 69 elderly patients aged 76.5+/-5.9 years with heart failure and 44 age-matched controls without heart failure between March 1997 and September 2000 at the Geriatric Cardiology Outpatient Clinic of the Heart Institute of Sao Paulo, Brazil. Events analyzed included death, hospitalization, and the combined end point of death or hospitalization. The study revealed that levels of triiodothyronine were lower in heart failure patients than in controls (89+/-23 vs. 101+/-16 ng/dL, p=0.001). During the follow-up period of 14.3+/-8.1 months there were 19 deaths and 33 hospitalizations in the heart failure group. The combined end point of death or hospitalization occurred in 38 patients. Triiodothyronine levels were lower in heart failure patients who had a cardiovascular event than in event-free patients (82.7+/-24.8 vs. 96.7+/-19.2 ng/dL, p=0.012). The odds ratio for events was 9.8 (95% confidence interval, 2.2-43, p=0.004) for patients in the lowest tertile of triiodothyronine, that is, lower than 80 ng/dL, compared with patients with levels above 80 ng/dL. The authors conclude that among elderly patients with heart failure, lower triiodothyronine concentrations are more prevalent and are associated with a worse prognosis.
The American Journal of Cardiology, 2000
In elderly patients with severe aortic stenosis, clinical evaluation can dictate decision making.... more In elderly patients with severe aortic stenosis, clinical evaluation can dictate decision making. Asymptomatic patients in normal sinus rhythm, without left atrial enlargement and without bundle branch block, can be safely followed clinically, regardless of echocardiographic findings.
Arquivos Brasileiros …, 2010
Uploads
Papers by Amit Nussbacher